Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens
currently in clinical use. However, the precise mechanisms of DOX's action are not fully …

Cancer is one of the main causes of death worldwide. To date, and despite the advances in
conventional treatment options, therapy in cancer is still far from optimal due to the non …

Pancreatic cancer is one of the harshest and most challenging cancers to treat, often labeled
as incurable. Chemotherapy continues to be the most popular treatment yet yields a very …

Breast cancer (BC) is one of the most widely diagnosed cancers and a leading cause of
cancer death among women worldwide. Globally, BC is the second most frequent cancer …

The liposome is the first nanomedicine transformed into the market and applied to human
patients. Since then, such phospholipid bilayer vesicles have undergone technological …

Breast cancer (BC) is the most frequently diagnosed malignant tumor among women in the
world. BC is the heterogeneous tumor with different subtypes including luminal A-like …

Breast cancer (BC) is the most prevalent type of cancer in the world and the main reason
women die from cancer. Due to the significant side effects of conventional treatments such …

Globally, breast cancer is the most diagnosed invasive cancer among women. Current
therapies (eg, chemotherapy) show numerous limitations due to the lack of selectivity and …

The increase in cancer cases is undoubtedly affecting the development of new therapeutic
approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size …

In this article, we describe a method of delivery of doxorubicin using a novel tumor-homing
peptide-based albumin nanoparticle system to triple-negative breast cancer cells (TNBC) …